China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

by · The Markets Daily

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

CPHI stock opened at $0.24 on Friday. The company has a fifty day moving average price of $0.22 and a 200-day moving average price of $0.22. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.44.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Stories